Avanos Medical releases a study that demonstrates clinical effectiveness of COOLIEF* Cooled RF in treating…
Digital Pharmacist (www.digitalpharmacist.com), a rapidly growing software company that powers digital communication and adherence solutions…
Satsuma Pharmaceuticals, Inc. (“Satsuma” or “the Company”), a clinical-stage biopharmaceutical company, today announced dosing of…
Data and analytics platform Premise Data announced today it was named an INFUSE Pacesetter by Gavi, the Vaccine Alliance—a privileged…
Dravet Syndrome, a catastrophic form of epilepsy, affects one in 15,700 children and adults in…
– Combination of regorafenib and nivolumab vs. regorafenib alone to be evaluated in patients with…
A powerful new message in Times Square from the Partnership for a Drug-Free New Jersey…
Menarini Ricerche today announced the publication of the results of a non-clinical study describing the…
Since the China launch earlier this year of an immuno-oncology drug at one-third the price of Merck’s…
-With this approval, Emgality is the only calcitonin gene-related peptide (CGRP) antibody indicated for the…